New Study Demonstrates Value of AI-Enabled EKG Algorithm in Routine Practice
Related Articles
Anumana Named to Fast Company’s 2026 Most Innovative Companies Awards
Recognition highlights Anumana’s leadership in AI-driven cardiovascular detection and clinical decision support CAMBRIDGE, Mass., March 24, 2026—Anumana, a leader in AI-powered cardiovascular detection algorithms, today announced it has been named…March 24, 2026
Novartis links up with Mayo Clinic spinout Anumana to develop ECG-reading AI
FIERCE Biotech: Heart disease remains the leading cause of death around the world, but a flood of tech developers are hoping that artificial intelligence software might be the key to…July 13, 2022
Anumana Receives First and Only FDA Clearance for ECG-AI Cardiac Amyloidosis Algorithm Using a Standard 12-Lead ECG
CAMBRIDGE, Mass., April 8, 2026—Anumana, Inc., a leader in cardiovascular AI, today announced U.S. Food and Drug Administration (FDA) clearance of its ECG-AI® algorithm for cardiac amyloidosis (CA) – the…April 08, 2026
Tech Companies Aim to Expand Use of Data Analytics in Healthcare
Health IT Analytics: For years, data analytics in healthcare has been a frequent buzzword among industry leaders. The ability to leverage AI, machine learning, and other technologies to gain actionable…April 14, 2021